CHROMOPHOBE RENAL CELL CARCINOMA

This adverse event was reported 45 times

CHROMOPHOBE RENAL CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VELAGLUCERASE ALFA 1 0.0005
1 LOMUSTINE 1 0.0004
2 GLUCAGON 1 0.0002
3 AMLODIPINE BESYLATE AND VALSARTAN 2 0.0002
4 EVEROLIMUS TABLETS 3 0.0002
5 ELETRIPTAN HYDROBROMIDE 1 0.0001
6 REPAGLINIDE 1 0.0001
7 AZATHIOPRINE 11 0.0001
8 CYCLOSPORINE 11 0.0001
9 RIFAXIMIN 2 0.0001
See all drugs enriched for association with CHROMOPHOBE RENAL CELL CARCINOMA